{'fraction_non_alphanumeric': 0.017050298380221655, 'fraction_numerical': 0.0017050298380221654, 'mean_word_length': 5.708571428571428, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Adiponectin as an adipose tissue hormone and its role in the metabolic syndrome and cardiovascular disease].

Adiponectin, is a novel hormone secreted by the adipose tissue. This active protein plays a role in the regulation of whole body energy homeostasis. It enhances insulin sensitivity and has antiatherogenic properties, reduces hepatic glucose production, and diminishes gluconeogenesis. Adiponectin accelerates the oxidation process of fatty acids in muscle cells, reduces triglycerides plasma concentration. In addition, plasma adiponectin levels negatively correlated with BMI and fat content. Numerous analyses have indicated that hypoadiponectinemia is a consequence of the development of obesity in childhood. The adiponectin secretion in newborn children is higher than in older, an child small for gestational age has lower plasma concentration of this protein. Clinical studies suggest that adiponectin deficiency associates with gestational diabetes in women. However, serum adiponectin levels in type 1 diabetes have not been elucidated, probably factors other than glucose and insulin play a significant role in adiponectin secretion in type 1 diabetes.